Literature DB >> 21323748

A topical Chinese herbal mixture improves epidermal permeability barrier function in normal murine skin.

Mona Man, Melanie Hupe, Donald Mackenzie, Hyunjung Kim, Yuko Oda, Debra Crumrine, Seung Hun Lee, Gemma Martin-Ezquerra, Carles Trullas, Theodora M Mauro, Kenneth R Feingold, Peter M Elias, Mao-Qiang Man.   

Abstract

Chinese herbal medicine (CHM) has been shown to have beneficial effects for both skin disorders with barrier abnormality and as skin care ingredients. Yet, how CHM exerts their benefits is unclear. As most, if not all, inflammatory dermatoses are accompanied by abnormal permeability barrier function, we assessed the effects of topical CHM extracts on epidermal permeability barrier function and their potential mechanisms. Topical CHM accelerated barrier recovery following acute barrier disruption. Epidermal lipid content and mRNA expression of fatty acid and ceramide synthetic enzymes increased following topical CHM treatment in addition to mRNA levels for the epidermal glucosylceramide transport protein, ATP-binding cassette A12. Likewise, CHM extract increased mRNA expression of antimicrobial peptides both in vivo and in vitro. These results demonstrate that the topical CHM extract enhances epidermal permeability barrier function, suggesting that topical CHM could provide an alternative regimen for the prevention/treatment of inflammatory dermatoses accompanied by barrier abnormalities.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323748      PMCID: PMC4548955          DOI: 10.1111/j.1600-0625.2010.01205.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  17 in total

1.  Barrier function regulates epidermal DNA synthesis.

Authors:  E Proksch; K R Feingold; M Q Man; P M Elias
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

2.  Inhibitory effects of Rumex japonicus Houtt. on the development of atopic dermatitis-like skin lesions in NC/Nga mice.

Authors:  H-S Lee; S-K Kim; J-B Han; H-M Choi; J-H Park; E-C Kim; M-S Choi; H-J An; J-Y Um; H-M Kim; B-I Min
Journal:  Br J Dermatol       Date:  2006-07       Impact factor: 9.302

3.  In human epidermis, beta-defensin 2 is packaged in lamellar bodies.

Authors:  A Oren; T Ganz; L Liu; T Meerloo
Journal:  Exp Mol Pathol       Date:  2003-04       Impact factor: 3.362

4.  Preparation and characterization of herbal creams for improvement of skin viscoelastic properties.

Authors:  M S Ahshawat; S Saraf; S Saraf
Journal:  Int J Cosmet Sci       Date:  2008-06       Impact factor: 2.970

5.  Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2.

Authors:  Caroline Lefévre; Stéphanie Audebert; Florence Jobard; Bakar Bouadjar; Hakima Lakhdar; Omar Boughdene-Stambouli; Claudine Blanchet-Bardon; Roland Heilig; Mario Foglio; Jean Weissenbach; Mark Lathrop; Jean-François Prud'homme; Judith Fischer
Journal:  Hum Mol Genet       Date:  2003-07-15       Impact factor: 6.150

6.  Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice.

Authors:  Yoshifumi Taniguchi; Keizo Kohno; Shin-ichiro Inoue; Satomi Koya-Miyata; Iwao Okamoto; Norie Arai; Kanso Iwaki; Masao Ikeda; Masashi Kurimoto
Journal:  Int Immunopharmacol       Date:  2003-09       Impact factor: 4.932

7.  Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction.

Authors:  M Mao-Qiang; B E Brown; S Wu-Pong; K R Feingold; P M Elias
Journal:  Arch Dermatol       Date:  1995-07

8.  Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens.

Authors:  Tiffany C Scharschmidt; Mao-Qiang Man; Yutaka Hatano; Debra Crumrine; Roshan Gunathilake; John P Sundberg; Kathleen A Silva; Theodora M Mauro; Melanie Hupe; Soyun Cho; Yan Wu; Anna Celli; Matthias Schmuth; Kenneth R Feingold; Peter M Elias
Journal:  J Allergy Clin Immunol       Date:  2009-09       Impact factor: 10.793

9.  Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers.

Authors:  Karin M Aberg; Mao-Qiang Man; Richard L Gallo; Tomas Ganz; Debra Crumrine; Barbara E Brown; Eung-Ho Choi; Dong-Kun Kim; Jens M Schröder; Kenneth R Feingold; Peter M Elias
Journal:  J Invest Dermatol       Date:  2007-10-18       Impact factor: 8.551

Review 10.  Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology.

Authors:  P M Elias; K R Feingold
Journal:  Semin Dermatol       Date:  1992-06
View more
  7 in total

1.  Topical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.

Authors:  George Man; Theodora M Mauro; Peggy L Kim; Melanie Hupe; Yongjiao Zhai; Richard Sun; Debbie Crumrine; Carolyn Cheung; Almudena Nuno-Gonzalez; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2014-07-31       Impact factor: 3.960

2.  Topical hesperidin improves epidermal permeability barrier function and epidermal differentiation in normal murine skin.

Authors:  Maihua Hou; Mona Man; Wenyan Man; Wenyuan Zhu; Melanie Hupe; Kyungho Park; Debra Crumrine; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2012-05       Impact factor: 3.960

3.  Topical apigenin improves epidermal permeability barrier homoeostasis in normal murine skin by divergent mechanisms.

Authors:  Maihua Hou; Richard Sun; Melanie Hupe; Peggy L Kim; Kyungho Park; Debra Crumrine; Tzu-Kai Lin; Juan Luis Santiago; Theodora M Mauro; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2013-03       Impact factor: 3.960

4.  sPLA2 and the epidermal barrier.

Authors:  Dusko Ilic; James M Bollinger; Michael Gelb; Theodora M Mauro
Journal:  Biochim Biophys Acta       Date:  2013-11-20

5.  Expression of epidermal CAMP changes in parallel with permeability barrier status.

Authors:  Marina Rodriguez-Martin; Gemma Martin-Ezquerra; Mao-Qiang Man; Melanie Hupe; Jong-Kyung Youm; Donald S Mackenzie; Soyun Cho; Carles Trullas; Walter M Holleran; Katherine A Radek; Peter M Elias
Journal:  J Invest Dermatol       Date:  2011-07-28       Impact factor: 8.551

6.  Topical apigenin alleviates cutaneous inflammation in murine models.

Authors:  Mao-Qiang Man; Melanie Hupe; Richard Sun; George Man; Theodora M Mauro; Peter M Elias
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-19       Impact factor: 2.629

7.  Barrier-restoring therapies in atopic dermatitis: current approaches and future perspectives.

Authors:  Y Valdman-Grinshpoun; D Ben-Amitai; A Zvulunov
Journal:  Dermatol Res Pract       Date:  2012-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.